Human IgM antibody therapy for HIV-1 infection.
Okada
N
N
Department of Molecular Biology, Nagoya City University School of Medicine, Nagoya, Aichi, Japan. drnoriko@med.nagoya-cu.ac.jp
Okada
H
H
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology; D005678:G(M2) Ganglioside / Q000276:immunology; D005732:Gangliosides / Q000276:immunology*; D015658:HIV Infections / Q000097:blood / Q000276:immunology / Q000628:therapy* / Q000821:virology; D015497:HIV-1 / Q000235:genetics / Q000254:growth & development / Q000276:immunology*; D006801:Humans; D007075:Immunoglobulin M / Q000276:immunology / Q000627:therapeutic use*; D007167:Immunotherapy; D012367:RNA, Viral; D017741:Survivors; D019562:Viral Load
D000911:Antibodies, Monoclonal; D005732:Gangliosides; D007075:Immunoglobulin M; D012367:RNA, Viral; D005678:G(M2) Ganglioside; D003165:Complement System Proteins